arcadegametable| There has been a final and successful case in the stock claim case of Sitron Medical Care! Xinpai will be punished for violating the law, and damaged shareholders can claim compensation

editor2024-05-27 11:52:093Economics

Log in to Sina Finance APP to search [Xinpi] to view more evaluation levels

Recently, Zhang Xiangbing, a lawyer from Jiangsu Boaixing Law Firm, which has represented many major impact cases, specifically reminded that the stock claim case of Sichuang Medical (Rights Protection) has been finalized and won! Xinpai will be punished for violating the law, and damaged shareholders can claim compensation. (Zhang Xiangbing's lawyer's column)

arcadegametable| There has been a final and successful case in the stock claim case of Sitron Medical Care! Xinpai will be punished for violating the law, and damaged shareholders can claim compensation

On January 9, 2024, Sichuang Medical Technology Co., Ltd.(hereinafter referred to asarcadegametable: Sichuang Yihui) issued an announcement stating that the company received the "Administrative Penalty Decision"([2023] No. 49) issued by the Zhejiang Securities Regulatory Bureau.

It was found that Sichuang Yihui and Zhang Lizhi had the following illegal facts: 1. Sichuang Yihui fabricated major false content in its public issuance documents;2. Sichuang Yihui's 2019 and 2020 annual reports contained false records. Our bureau has decided to impose administrative penalties on Sichuang Medical for benefiting Zhang Lizhong.

Lawyer Zhang Xiangbing said that the judicial interpretation of the Supreme People's Court stipulates that if the information disclosure obligor violates laws, administrative regulations, rules and normative documents formulated by regulatory authorities on information disclosure, and constitutes a false statement, the injured investor can sue for compensation in accordance with the law. The actual losses incurred include: loss of investment balance, commissions and stamp duty on the loss of investment balance.

Currently, Lawyer Zhang Xiangbing is representing Sitron Medical Care investors in claims litigation. The claim conditions are:

Impaired investors who bought Sistron Medical shares between April 30, 2020 and October 28, 2022 and still held the shares at the close of trading on October 28, 2022 can sue for losses. (Sichuang Medical Benefit Rights Protection Entrance)

For investors who meet the conditions for claim, please contact the lawyer team of Zhang Xiangbing of Jiangsu Boaixing Law Firm as soon as possible and provide the following documents: a copy of their ID card, a securities account inquiry confirmation form stamped with the seal of the securities company's business department, and the original stock transaction statement (the stock was purchased for the first time since the first time), detailed contact information.

(This article was contributed by Lawyer Zhang Xiangbing of Jiangsu Boaixing Law Firm and does not represent Sina Finance's position. Lawyer Zhang Xiangbing, a securities rights lawyer. Graduated from Southwest University of Political Science and Law with a master's degree in law. He is good at representing securities litigation and financial rights protection cases, and has many years of experience in investor rights protection litigation. Successfully represented or is representing hundreds of investor rights protection cases, and has represented many cases with significant social impact and landmark significance. The investor v. Solin Shares (Rights Protection) and Dong Jiangao cases were selected as one of the top ten typical cases of securities misrepresentation liability disputes by Shenzhen Intermediate People's Court; the Bank of China's "Crude Oil Treasure" civil case was selected as one of the top ten commercial cases in national courts in 2020)